Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
4.640
+0.130 (2.88%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $528.65 million as of April 28, 2025. Its market cap has decreased by -16.86% in one year.
Market Cap
528.65M
Enterprise Value
259.04M
1-Year Change
-16.86%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $528.65M, an increase of 325.40%. That is a compound annual growth rate of 35.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 528.65M | -38.64% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |